Loading...
XNAS
SKYE
Market cap7mUSD
Oct 08, Last price  
1.68USD
1D
1.82%
1Q
-69.57%
Jan 2017
-99.72%
IPO
-99.98%
Name

Skye Bioscience Inc

Chart & performance

D1W1MN
XNAS:SKYE chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
39.88%
Rev. gr., 5y
%
Revenues
0
16,243339,926000000000000
Net income
-56m
L+110.50%
4,509-120,403-2,734,000-4,841,161-3,178,000-3,094,000-19,194,0001,052,000-6,561,000-8,522,182-19,481,602-37,644,784-26,567,123-55,924,814
CFO
-43m
L+70.63%
1,928-14,495-1,755,208-3,727,989-3,552,941-3,298,213-3,943,014-6,027,941-6,054,131-6,474,888-12,744,072-13,952,178-25,237,480-43,062,529

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.

Key people

Paul Grayson
Independent Chairman of the Board · since 2024
Punit Dhillon
President, Chief Executive Officer, Director · since 2024
Kaitlyn Arsenault
Chief Financial Officer · since 2021
Christopher Twitty
Chief Scientific Officer · since 2024
Puneet Arora
Chief Medical Officer · since 2024
Tuan Tu Diep
Chief Development Officer · since 2022
Andrew Schwab
Director · since 2023
Deborah Charych
Independent Director · since 2023
Annalisa Jenkins
Independent Director · since 2024
Karen Smith
Independent Director · since 2024
URL
https://skyebioscience.com/
IPO date
Feb 24, 2014
Employees
Domiciled in
US
Incorporated in
US
Legal address
C/O Corporate Direct, Inc.
2248 Meridian Boulevard
Suite H
Minden, NV 89423
US
Headquarters
6317 South West 16th Street
Miami, FL 33155
US
Previous name
Load Guard Logistics, Inc.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT